The Korean Journal of Laboratory Medicine 2011-04-01

Erythroleukemia relapsing as precursor B-cell lymphoblastic leukemia.

Borae G Park, Chan-Jeoung Park, Seongsoo Jang, Eul Ju Seo, Hyun-Sook Chi, Jung-Hee Lee

Index: Korean J. Lab. Med. 31(2) , 81-5, (2011)

Full Text: HTML

Abstract

AML relapsing as ALL has rarely been reported. We describe the case of a 62-yr-old man who was diagnosed with erythroleukemia with a complex karyotype and achieved complete hematologic and cytogenetic remission after induction chemotherapy. However, 4 months after the initial diagnosis, he showed relapse with blasts showing a different morphology and immunophenotype and was diagnosed with precursor B-cell ALL. The relapsing precursor B-cell ALL presented with the same leukemic clones as the primary erythroleukemia. Cytogenetic analysis of his bone marrow (BM) at the time of the primary erythroleukemia showed complex karyotypic abnormalities, including monosomy 5 and monosomy 7. At relapse, his BM showed reemergence of these leukemic clones of complex karyotypic abnormalities with clonal switch. To our knowledge, this is the first case of a lineage switch from erythroleukemia to ALL.


Related Compounds

Related Articles:

Semiquinone free radical formation by daunorubicin aglycone incorporated into the cellular membranes of intact Chinese hamster ovary cells.

1996-01-01

[Free Radic. Res. 24(1) , 9-18, (1996)]

Biotransformation of aklanonic acid by blocked mutants of anthracycline-producing strains of Streptomyces galilaeus and Streptomyces peucetius.

1986-01-01

[J. Basic Microbiol. 26(4) , 249-55, (1986)]

Synthesis and biological activity of (7S)-O-epoxyalkyl derivatives of daunomycinone.

1985-12-01

[J. Antibiot. 38(12) , 1714-8, (1985)]

Synthesis and cytotoxic activity of a new potent daunomycinone derivative.

2002-12-16

[Bioorg. Med. Chem. Lett. 12(24) , 3505-7, (2002)]

Method for analysis, and distribution profile, of covalently-linked ferritin-daunorubicin conjugate in the blood of trypanosome-infected mice.

1992-01-01

[J. Pharm. Pharmacol. 44(1) , 48-51, (1992)]

More Articles...